These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18203755)

  • 1. Brachydactyly type A2 associated with a defect in proGDF5 processing.
    Plöger F; Seemann P; Schmidt-von Kegler M; Lehmann K; Seidel J; Kjaer KW; Pohl J; Mundlos S
    Hum Mol Genet; 2008 May; 17(9):1222-33. PubMed ID: 18203755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mutational spectrum of brachydactyly type C.
    Everman DB; Bartels CF; Yang Y; Yanamandra N; Goodman FR; Mendoza-Londono JR; Savarirayan R; White SM; Graham JM; Gale RP; Svarch E; Newman WG; Kleckers AR; Francomano CA; Govindaiah V; Singh L; Morrison S; Thomas JT; Warman ML
    Am J Med Genet; 2002 Oct; 112(3):291-6. PubMed ID: 12357473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of two novel missense mutations in the GDF5 proregion that reduce protein activity and are associated with brachydactyly type C.
    Stange K; Thieme T; Hertel K; Kuhfahl S; Janecke AR; Piza-Katzer H; Penttinen M; Hietala M; Dathe K; Mundlos S; Schwarz E; Seemann P
    J Mol Biol; 2014 Sep; 426(19):3221-3231. PubMed ID: 25092592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2.
    Seemann P; Schwappacher R; Kjaer KW; Krakow D; Lehmann K; Dawson K; Stricker S; Pohl J; Plöger F; Staub E; Nickel J; Sebald W; Knaus P; Mundlos S
    J Clin Invest; 2005 Sep; 115(9):2373-81. PubMed ID: 16127465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation in the receptor binding site of GDF5 causes Mohr-Wriedt brachydactyly type A2.
    Kjaer KW; Eiberg H; Hansen L; van der Hagen CB; Rosendahl K; Tommerup N; Mundlos S
    J Med Genet; 2006 Mar; 43(3):225-31. PubMed ID: 16014698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and characterization of a human BMP-7 variant with improved biochemical properties.
    Swencki-Underwood B; Mills JK; Vennarini J; Boakye K; Luo J; Pomerantz S; Cunningham MR; Farrell FX; Naso MF; Amegadzie B
    Protein Expr Purif; 2008 Feb; 57(2):312-9. PubMed ID: 17977014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in GDF5 presenting as semidominant brachydactyly A1.
    Byrnes AM; Racacho L; Nikkel SM; Xiao F; MacDonald H; Underhill TM; Bulman DE
    Hum Mutat; 2010 Oct; 31(10):1155-62. PubMed ID: 20683927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Length of the linking domain of human pro-tumor necrosis factor determines the cleavage processing.
    Tang P; Hung M-C ; Klostergaard J
    Biochemistry; 1996 Jun; 35(25):8226-33. PubMed ID: 8679577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice.
    Masuya H; Nishida K; Furuichi T; Toki H; Nishimura G; Kawabata H; Yokoyama H; Yoshida A; Tominaga S; Nagano J; Shimizu A; Wakana S; Gondo Y; Noda T; Shiroishi T; Ikegawa S
    Hum Mol Genet; 2007 Oct; 16(19):2366-75. PubMed ID: 17656374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable hand and foot abnormalities in family with congenital vertical talus and CDMP-1 gene mutation.
    Dobbs MB; Gurnett CA; Robarge J; Gordon JE; Morcuende JA; Bowcock AM
    J Orthop Res; 2005 Nov; 23(6):1490-4. PubMed ID: 16005596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachydactyly type C caused by a homozygous missense mutation in the prodomain of CDMP1.
    Schwabe GC; Türkmen S; Leschik G; Palanduz S; Stöver B; Goecke TO; Mundlos S
    Am J Med Genet A; 2004 Feb; 124A(4):356-63. PubMed ID: 14735582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterotypy in the N-terminal region of growth/differentiation factor 5 (GDF5) mature protein during teleost evolution.
    Fujimura K; Terai Y; Ishiguro N; Miya M; Nishida M; Okada N
    Mol Biol Evol; 2008 May; 25(5):797-800. PubMed ID: 18296700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous propeptide processing of mini-stromelysin-1 mutants blocked by APMA ((4-Aminophenyl)mercuric acetate).
    Galazka G; Windsor LJ; Birkedal-Hansen H; Engler JA
    Biochemistry; 1999 Jan; 38(4):1316-22. PubMed ID: 9930993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical and structural characterization of a folded core domain within the proregion of growth and differentiation factor-5.
    Thieme T; Patzschke R; Job F; Liebold J; Seemann P; Lilie H; Balbach J; Schwarz E
    FEBS J; 2014 Nov; 281(21):4866-77. PubMed ID: 25174448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monomeric and dimeric GDF-5 show equal type I receptor binding and oligomerization capability and have the same biological activity.
    Sieber C; Plöger F; Schwappacher R; Bechtold R; Hanke M; Kawai S; Muraki Y; Katsuura M; Kimura M; Rechtman MM; Henis YI; Pohl J; Knaus P
    Biol Chem; 2006 Apr; 387(4):451-60. PubMed ID: 16606344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of nerve growth factor: the role of basic amino acid clusters in the pro-region.
    Mouri A; Nomoto H; Furukawa S
    Biochem Biophys Res Commun; 2007 Feb; 353(4):1056-62. PubMed ID: 17207774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage-site mutagenesis alters post-translation processing of Pro-CCK in AtT-20 cells.
    Pratt JS; Blum A; Vishnuvardhan D; Kitagawa K; Beinfeld MC
    Biochemistry; 2004 Jul; 43(29):9502-11. PubMed ID: 15260493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel point mutations in GDF5 associated with two distinct limb malformations in Chinese: brachydactyly type C and proximal symphalangism.
    Yang W; Cao L; Liu W; Jiang L; Sun M; Zhang D; Wang S; Lo WHY; Luo Y; Zhang X
    J Hum Genet; 2008; 53(4):368-374. PubMed ID: 18283415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of the disulfide bridge pattern of the recombinant human growth and differentiation factor 5 dimer and the interchain Cys/Ala mutant monomer.
    Trachsel C; Kämpfer U; Bechtold R; Schaller J; Schürch S
    Anal Biochem; 2009 Jul; 390(2):103-8. PubMed ID: 19393216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound heterozygosity for GDF5 in Du Pan type chondrodysplasia.
    Douzgou S; Lehmann K; Mingarelli R; Mundlos S; Dallapiccola B
    Am J Med Genet A; 2008 Aug; 146A(16):2116-21. PubMed ID: 18629880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.